A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer
Public ClinicalTrials.gov record NCT00055419. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to learn about the safety of cetuximab in patients with stage IV colorectal cancer, and who may benefit from cetuximab.
Study identification
- NCT ID
- NCT00055419
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 744 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2003
- Primary completion
- Jun 30, 2004
- Completion
- Jul 31, 2004
- Last update posted
- Apr 8, 2010
2003 – 2004
United States locations
- U.S. sites
- 29
- U.S. states
- 24
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ImClone Investigational Site | Bakersfield | California | 93309 | — |
| ImClone Investigational Site | Los Angeles | California | 90025 | — |
| ImClone Investigational Site | Denver | Colorado | 80218 | — |
| ImClone Investigational Site | Torrington | Connecticut | 06790 | — |
| ImClone Investigational Site | Washington D.C. | District of Columbia | 20057 | — |
| ImClone Investigational Site | Jacksonville | Florida | 32207 | — |
| ImClone Investigational Site | Miami | Florida | 33176 | — |
| ImClone Investigational Site | Orlando | Florida | 32804 | — |
| ImClone Investigational Site | Atlanta | Georgia | 30318 | — |
| ImClone Investigational Site | Decatur | Illinois | 62526 | — |
| ImClone Investigational Site | Louisville | Kentucky | 40202 | — |
| ImClone Investigational Site | New Orleans | Louisiana | 70121 | — |
| ImClone Investigational Site | Baltimore | Maryland | 21204 | — |
| ImClone Investigational Site | Ypsilanti | Michigan | 48198 | — |
| ImClone Investigational Site | Minneapolis | Minnesota | 55416 | — |
| ImClone Investigational Site | Saint Charles | Missouri | 63301 | — |
| ImClone Investigational Site | Great Falls | Montana | 59405 | — |
| ImClone Investigational Site | Las Vegas | Nevada | 89109 | — |
| ImClone Investigational Site | Voorhees Township | New Jersey | 08043 | — |
| ImClone Investigational Site | East Setauket | New York | 11733 | — |
| ImClone Investigational Site | Latham | New York | 12110 | — |
| ImClone Investigational Site | New York | New York | 10016 | — |
| ImClone Investigational Site | Cleveland | Ohio | 44134 | — |
| ImClone Investigational Site | Portland | Oregon | 97239 | — |
| ImClone Investigational Site | Greenville | South Carolina | 29605 | — |
| ImClone Investigational Site | Memphis | Tennessee | 38104 | — |
| ImClone Investigational Site | Dallas | Texas | 75230 | — |
| ImClone Investigational Site | Norfolk | Virginia | 23502 | — |
| ImClone Investigational Site | Green Bay | Wisconsin | 54307 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00055419, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2010 · Synced Sep 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00055419 live on ClinicalTrials.gov.